K-Ras-Activated Cells Can Develop into Lung Tumors When Runx3-Mediated Tumor Suppressor Pathways Are Abrogated
10.14348/molcells.2020.0182
Saved in:
Main Authors: | Lee, You-Soub, Lee, Ja-Yeol, Song, Soo-Hyun, Kim, Da-Mi, Lee, Jung-Won, Chi, Xin-Zi, Ito, Yoshiaki, Bae, Suk-Chul |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Language: | English |
Published: |
KOREAN SOC MOLECULAR & CELLULAR BIOLOGY
2023
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/239104 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRAS status
by: Omar, M.F.M., et al.
Published: (2014) -
RAS oncogenic signal upregulates EZH2 in pancreatic cancer
by: Fujii, S., et al.
Published: (2016) -
The multiple interactions of RUNX with the hippo–YAP pathway
by: Chuang, Linda Shyue Huey, et al.
Published: (2022) -
Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor
by: Guo, W.-H., et al.
Published: (2014) -
RUNX3 acts as a tumor suppressor in breast cancer by targeting estrogen receptor α
by: Huang, B., et al.
Published: (2014)